ALLURION TECHNOLOGIES INC (ALUR)
OTCHealth CareMedical - DevicesSnapshot 2026-09-04
$1.12+1.82%
Close 2026-09-04 · 1-day change
OTCHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ALUR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | 12.6 | 15.2 | 32.1 | 53.5 | 64.2 | — |
| Cost of Revenues | 6.0 | 5.7 | 10.6 | 12.0 | 13.5 | — |
| Gross Profit | 6.6 | 9.6 | 21.5 | 41.5 | 50.7 | — |
| Operating Expenses & Income | ||||||
| R&D Expenses | 5.9 | 7.6 | 17.4 | 27.7 | 17.0 | — |
| Operating Income | (26.6) | (30.2) | (50.2) | (79.1) | (32.0) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | 2.3 | 10.6 | 4.4 | — |
| Other Non-Operating Income / Expenses | (6.7) | 1.5 | 24.8 | (3.5) | (5.6) | — |
| EBT, Incl. Unusual Items | (33.3) | (28.7) | (25.4) | (82.6) | (37.6) | — |
| Income Tax Expense | 0.0 | 0.1 | 0.7 | 0.3 | 0.1 | — |
| Net Income | ||||||
| Net Income | (33.3) | (28.8) | (26.1) | (82.8) | (37.7) | — |
| Per Share | ||||||
| Basic EPS | (2.50) | (3.81) | (11.64) | (59.38) | (37.75) | — |
| Diluted EPS | (2.50) | (3.81) | (11.64) | (59.38) | (37.75) | — |
| Revenue per Share | 0.94 | — | — | — | — | — |
| Basic Weighted Avg Shares | 13.4 | 7.5 | 2.2 | 1.4 | 1.1 | — |
| Diluted Weighted Avg Shares | 13.4 | 7.5 | 2.2 | 1.4 | 1.1 | — |
| Supplemental | ||||||
| EBITDA | — | (29.2) | (49.2) | (78.3) | (31.1) | — |
| EBIT | (26.6) | (30.2) | (50.2) | (79.1) | (32.0) | — |
| Effective Tax Rate | -0.0% | — | — | -0.3% | -0.4% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.